Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning
Author(s) -
Gerard Kan,
Ian Jenkins,
Gopala K. Rangan,
Andrew J. Woodroffe,
H. Rhodes,
David A. Joyce
Publication year - 2003
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfg432
Subject(s) - medicine , methanol poisoning , intensive care medicine , hemodialysis , emergency medicine , methanol , chemistry , organic chemistry
Methanol (MeOH) is a toxic alcohol present in many solvents and antifreeze solutions. Ingested MeOH undergoes enzymatic oxidation to toxic formic acid, resulting in acidosis, neurotoxicity and death in severe poisoning. Treatment relies on antidote administration (fomepizole or ethanol) to antagonize MeOH oxidation, folic acid to facilitate the catabolism of formic acid, correction of acidosis and dialysis to accelerate MeOHelimination [1]. Intermittent haemodialysis (HD) is used conventionally [1]. Continuous veno-venous haemodiafiltration (CVVHDF) has not been formally evaluated against this standard. Here we compare the relative efficiencies of HD and CVVHDF in accelerating MeOH elimination and correcting metabolic abnormalities in three severely poisoned patients, seen simultaneously in two tertiary referral hospitals. At that time, only CVVHDF was available in the Intensive Care Department of the hospital that treated two patients. The third patient received HD. Toxicokinetics and clinical outcomes of CVVHDF and HD treated patients were compared.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom